AI-powered ‘MesoGraph’ tool could help clinicians diagnose cancer
Around 3,000 new cases of mesothelioma are diagnosed in the US every year
Read More
Tag: mesothelioma
Opdivo, Yervoy combination approved to treat malignant pleural mesothelioma
Combination immunotherapy treatment approved in the EU for first-line treatment of adults with unresectable MPM
Read More
MSD, Verastem, CR UK to trial new immunotherapy combo
MSD, Verastem and Cancer Research UK are to trial a new combination of immunotherapy drugs as potential treatment for mesothelioma, non small cell lung and pancreatic cancers.
Read More
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
